|
AIDSinfo E-News: Offering HIV/AIDS Research, Clinical Trials, Prevention, and Treatment Information. |
|
AIDSinfo At-a-Glance Issue No. 4January 27, 2006
AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.
National Black HIV/AIDS Awareness Day is Around
the Corner February 7, 2006, marks
National Black HIV/AIDS Awareness Day, when local and national events will
strive to educate African Americans and others about HIV/AIDS, encourage
testing, and motivate communities throughout the country to get involved
in the fight against HIV/AIDS. This annual event was created by the Community Capacity Building Coalition
and is
funded by the
Centers for Disease Control and Prevention (CDC).
AIDSinfo has put together a page commemorating this day with helpful links to sites related to National Black HIV/AIDS Awareness Day, including information on current vaccine research, health disparities, and HIV/AIDS statistics. We hope you will find this page helpful and encourage you to participate in National Black HIV/AIDS Awareness Day this year.
TMC125—A Second Generation NNRTI in
Phase III Clinical Trials
TMC125, also known as etravirine, is an investigational antiretroviral in the same drug class (NNRTI) as Sustiva (efavirenz) and Viramune (nevirapine). Not only is TMC125 active against Sustiva- and Viramune-resistant HIV, recent research suggests it may be harder for HIV to become resistant to this “next generation” NNRTI. Read more about TMC125 here. For information on clinical trials using TMC125, click here.
ClinicalTrials.gov Info
New HIV/AIDS trials have been added to ClinicalTrials.gov
in the last 30 days:
click here. Please send comments or suggestions to ContactUs@aidsinfo.nih.gov
ISSN 1558-3228 |
|
|
|
You are currently subscribed to %%list.name%% as:
%%emailaddr%% Subscribe to AIDSinfo list serv here. |
|
Contact AIDSinfo Click on the Live Help button on the AIDSinfo home page
and communicate with the staff in “real time.” |